DEFINITIVE PROXY STMT

Company

GT Biopharma, Inc.

Filed

July 21, 1995

Period of Report

August 15, 1995

Accession Number

0000950131-95-001926

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →